|
ActivX Biosciences, Inc. was acquired by Kyorin Pharmaceutical Co., Ltd. in 2004. |
|||
|
|
|||
|
Amira Pharmaceuticals was acquired by Bristol-Myers Squibb in 2011. |
|||
|
|
|||
|
Arakis Ltd. was acquired by Sosei Co. Ltd. in 2005. |
|||
|
|
|||
|
Arpida Ltd. was focused on the development of novel antibiotic drugs. |
|||
|
|
|||
|
Cabrellis Pharmaceuticals Corp. Cabrellis Pharmaceuticals Corp. was acquired by Pharmion Corporation in 2006. |
|||
|
|
|||
|
CombioA/S was acquired by Arpida Ltd. in 2004. |
|||
|
|
|||
|
Conforma Therapeutics Corp. was acquired by Biogen Idec in 2006. |
|||
|
|
|||
|
Corus Pharma, Inc. was acquired by Gilead Sciences, Inc. in 2006. |
|||
|
|
|||
|
FoldRx Pharmaceuticals, Inc. was acquired by Pfizer Inc. in 2010. |
|||
|
|
|||
|
Gloucester Pharmaceuticals was acquired by Celgene Corporation in 2010 |
|||
|
|
|||
|
InSound Medical, Inc. was acquired by Sonova Holding AG in 2010. |
|||
|
|
|||
|
Neurodan A/S was acquired by Otto Bock GmbH in 2005. |
|||
|
|
|||
|
Novexel S.A. was acquired by AstraZeneca in 2010. |
|||
|
|
|||
|
Panacos Pharmaceuticals, Inc. developed small molecule drugs against infectious disease. |
|||
|
|
|||
|
Protein Forest Inc. was acquired by ProteinSimple Inc. in 2009. |
|||
|
|
|||
|
Salmedix, Inc. was acquired by Cephalon, Inc. in 2005. |
|||
|
|
|||
|
Sapphire Therapeutics, Inc. was acquired by Helsinn S.A. in 2009. |
|||
|
|
|||
|
Sosei Co. Ltd. acquired Arakis Ltd. in 2005. |
|||
|
|
|||
|
Synosia was acquired by Biotie Therapies Corporation in 2011. |
|||
|
|
|||
|
Thiakis, Ltd. was acquired by Wyeth Pharmaceuticals in 2008. |
|||
|
|
|||
|
ZymoGenetics, Inc. was acquired by Bristol-Myers Squibb in 2010. |
|||
|
|
|||